#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Discussion
1-1	0-2	4.	_	_	_	_
1-2	3-13	Discussion	abstract	new	_	_

#Text=Naturally , as the VAD and the controller are implanted in humans , because their lifespan depends largely on the suitability of the pump control , we must have great certainty in the robustness of the control algorithms .
2-1	14-23	Naturally	_	_	_	_
2-2	24-25	,	_	_	_	_
2-3	26-28	as	_	_	_	_
2-4	29-32	the	abstract[2]	new[2]	_	_
2-5	33-36	VAD	abstract[2]	new[2]	_	_
2-6	37-40	and	_	_	_	_
2-7	41-44	the	object[3]	new[3]	coref	9-11[69_3]
2-8	45-55	controller	object[3]	new[3]	_	_
2-9	56-59	are	_	_	_	_
2-10	60-69	implanted	_	_	_	_
2-11	70-72	in	_	_	_	_
2-12	73-79	humans	person	new	ana	2-15
2-13	80-81	,	_	_	_	_
2-14	82-89	because	_	_	_	_
2-15	90-95	their	person|abstract[6]	giv|new[6]	_	_
2-16	96-104	lifespan	abstract[6]	new[6]	_	_
2-17	105-112	depends	_	_	_	_
2-18	113-120	largely	_	_	_	_
2-19	121-123	on	_	_	_	_
2-20	124-127	the	abstract[7]	new[7]	_	_
2-21	128-139	suitability	abstract[7]	new[7]	_	_
2-22	140-142	of	abstract[7]	new[7]	_	_
2-23	143-146	the	abstract[7]|event[9]	new[7]|new[9]	coref	2-37[0_9]
2-24	147-151	pump	abstract[7]|object|event[9]	new[7]|new|new[9]	coref	8-1[61_0]
2-25	152-159	control	abstract[7]|event[9]	new[7]|new[9]	_	_
2-26	160-161	,	_	_	_	_
2-27	162-164	we	person	acc	ana	7-1
2-28	165-169	must	_	_	_	_
2-29	170-174	have	_	_	_	_
2-30	175-180	great	abstract[11]	new[11]	_	_
2-31	181-190	certainty	abstract[11]	new[11]	_	_
2-32	191-193	in	abstract[11]	new[11]	_	_
2-33	194-197	the	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-34	198-208	robustness	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-35	209-211	of	abstract[11]|abstract[12]	new[11]|new[12]	_	_
2-36	212-215	the	abstract[11]|abstract[12]|abstract[14]	new[11]|new[12]|new[14]	_	_
2-37	216-223	control	abstract[11]|abstract[12]|event|abstract[14]	new[11]|new[12]|giv|new[14]	coref	4-7[30_0]
2-38	224-234	algorithms	abstract[11]|abstract[12]|abstract[14]	new[11]|new[12]|new[14]	_	_
2-39	235-236	.	_	_	_	_

#Text=Continuous flow for VADs may allow simulated pulses ; however , until the date of circulatory assistance , despite tolerance to left ventricular and Pao , the continuous flow rate is traditionally of a medium constant rotation , which always decreases the pressure pulse .
3-1	237-247	Continuous	abstract[15]	new[15]	coref	3-29[0_15]
3-2	248-252	flow	abstract[15]	new[15]	_	_
3-3	253-256	for	abstract[15]	new[15]	_	_
3-4	257-261	VADs	abstract[15]|abstract	new[15]|new	_	_
3-5	262-265	may	_	_	_	_
3-6	266-271	allow	_	_	_	_
3-7	272-281	simulated	abstract[17]	new[17]	_	_
3-8	282-288	pulses	abstract[17]	new[17]	_	_
3-9	289-290	;	_	_	_	_
3-10	291-298	however	time[18]	new[18]	_	_
3-11	299-300	,	time[18]	new[18]	_	_
3-12	301-306	until	time[18]	new[18]	_	_
3-13	307-310	the	time[18]	new[18]	_	_
3-14	311-315	date	time[18]	new[18]	_	_
3-15	316-318	of	time[18]	new[18]	_	_
3-16	319-330	circulatory	time[18]|place|event[20]	new[18]|new|new[20]	_	_
3-17	331-341	assistance	time[18]|event[20]	new[18]|new[20]	_	_
3-18	342-343	,	time[18]	new[18]	_	_
3-19	344-351	despite	time[18]	new[18]	_	_
3-20	352-361	tolerance	time[18]|abstract	new[18]|new	_	_
3-21	362-364	to	_	_	_	_
3-22	365-369	left	_	_	_	_
3-23	370-381	ventricular	abstract	new	_	_
3-24	382-385	and	_	_	_	_
3-25	386-389	Pao	object	new	_	_
3-26	390-391	,	_	_	_	_
3-27	392-395	the	abstract[25]	new[25]	coref	10-13[82_25]
3-28	396-406	continuous	abstract[25]	new[25]	_	_
3-29	407-411	flow	abstract|abstract[25]	giv|new[25]	coref	4-16
3-30	412-416	rate	abstract[25]	new[25]	_	_
3-31	417-419	is	_	_	_	_
3-32	420-433	traditionally	abstract[26]	new[26]	_	_
3-33	434-436	of	abstract[26]	new[26]	_	_
3-34	437-438	a	abstract[26]	new[26]	_	_
3-35	439-445	medium	abstract[26]	new[26]	_	_
3-36	446-454	constant	abstract[26]	new[26]	_	_
3-37	455-463	rotation	abstract[26]	new[26]	_	_
3-38	464-465	,	_	_	_	_
3-39	466-471	which	_	_	_	_
3-40	472-478	always	_	_	_	_
3-41	479-488	decreases	_	_	_	_
3-42	489-492	the	event[28]	new[28]	_	_
3-43	493-501	pressure	abstract|event[28]	new|new[28]	coref	4-18
3-44	502-507	pulse	event[28]	new[28]	_	_
3-45	508-509	.	_	_	_	_

#Text=These types of devices generally require precise control and the use of sensors to measure flow and pressure .
4-1	510-515	These	object[29]	new[29]	coref	5-1[35_29]
4-2	516-521	types	object[29]	new[29]	_	_
4-3	522-524	of	object[29]	new[29]	_	_
4-4	525-532	devices	object[29]	new[29]	_	_
4-5	533-542	generally	_	_	_	_
4-6	543-550	require	_	_	_	_
4-7	551-558	precise	event[30]	giv[30]	coref	10-3[0_30]
4-8	559-566	control	event[30]	giv[30]	_	_
4-9	567-570	and	_	_	_	_
4-10	571-574	the	abstract[31]	new[31]	_	_
4-11	575-578	use	abstract[31]	new[31]	_	_
4-12	579-581	of	abstract[31]	new[31]	_	_
4-13	582-589	sensors	abstract[31]|object	new[31]|new	coref	6-7[43_0]
4-14	590-592	to	_	_	_	_
4-15	593-600	measure	_	_	_	_
4-16	601-605	flow	abstract	giv	coref	8-3
4-17	606-609	and	_	_	_	_
4-18	610-618	pressure	abstract	giv	coref	8-15
4-19	619-620	.	_	_	_	_

#Text=These devices are not reliable , owing to clinical issues such as routine calibration and blood clotting .
5-1	621-626	These	object[35]	giv[35]	_	_
5-2	627-634	devices	object[35]	giv[35]	_	_
5-3	635-638	are	_	_	_	_
5-4	639-642	not	_	_	_	_
5-5	643-651	reliable	_	_	_	_
5-6	652-653	,	_	_	_	_
5-7	654-659	owing	_	_	_	_
5-8	660-662	to	_	_	_	_
5-9	663-671	clinical	abstract[36]	new[36]	_	_
5-10	672-678	issues	abstract[36]	new[36]	_	_
5-11	679-683	such	abstract[36]	new[36]	_	_
5-12	684-686	as	abstract[36]	new[36]	_	_
5-13	687-694	routine	abstract[36]|abstract[37]	new[36]|new[37]	_	_
5-14	695-706	calibration	abstract[36]|abstract[37]	new[36]|new[37]	_	_
5-15	707-710	and	abstract[36]	new[36]	_	_
5-16	711-716	blood	abstract[36]|substance|abstract[39]	new[36]|new|new[39]	_	_
5-17	717-725	clotting	abstract[36]|abstract[39]	new[36]|new[39]	_	_
5-18	726-727	.	_	_	_	_

#Text=These concerns regarding the reliability of implantable sensors have led to the search for non-invasive , sensorless approaches to identifying analog cardiac preload .
6-1	728-733	These	abstract[40]	new[40]	_	_
6-2	734-742	concerns	abstract[40]	new[40]	_	_
6-3	743-752	regarding	_	_	_	_
6-4	753-756	the	abstract[41]	new[41]	_	_
6-5	757-768	reliability	abstract[41]	new[41]	_	_
6-6	769-771	of	abstract[41]	new[41]	_	_
6-7	772-783	implantable	abstract[41]|object|object[43]	new[41]|new|giv[43]	_	_
6-8	784-791	sensors	abstract[41]|object[43]	new[41]|giv[43]	_	_
6-9	792-796	have	_	_	_	_
6-10	797-800	led	_	_	_	_
6-11	801-803	to	_	_	_	_
6-12	804-807	the	abstract[44]	new[44]	_	_
6-13	808-814	search	abstract[44]	new[44]	_	_
6-14	815-818	for	abstract[44]	new[44]	_	_
6-15	819-831	non-invasive	abstract[44]|abstract[46]	new[44]|new[46]	coref	13-22[0_46]
6-16	832-833	,	abstract[44]|abstract[46]	new[44]|new[46]	_	_
6-17	834-844	sensorless	abstract[44]|abstract|abstract[46]	new[44]|new|new[46]	coref	7-23
6-18	845-855	approaches	abstract[44]|abstract[46]	new[44]|new[46]	_	_
6-19	856-858	to	_	_	_	_
6-20	859-870	identifying	_	_	_	_
6-21	871-877	analog	abstract[48]	new[48]	coref	12-11[0_48]
6-22	878-885	cardiac	person|abstract[48]	new|new[48]	_	_
6-23	886-893	preload	abstract[48]	new[48]	_	_
6-24	894-895	.	_	_	_	_

#Text=We now believe that non-invasive technology has advanced to a level where it can be considered for long-term implantation , combined with sensorless signals , to form a robust control system that provides physiological behavior to RBPs .
7-1	896-898	We	person	giv	ana	9-26
7-2	899-902	now	_	_	_	_
7-3	903-910	believe	_	_	_	_
7-4	911-915	that	_	_	_	_
7-5	916-928	non-invasive	abstract[50]	new[50]	_	_
7-6	929-939	technology	abstract[50]	new[50]	_	_
7-7	940-943	has	_	_	_	_
7-8	944-952	advanced	_	_	_	_
7-9	953-955	to	_	_	_	_
7-10	956-957	a	abstract[51]	new[51]	ana	7-13[0_51]
7-11	958-963	level	abstract[51]	new[51]	_	_
7-12	964-969	where	_	_	_	_
7-13	970-972	it	abstract	giv	_	_
7-14	973-976	can	_	_	_	_
7-15	977-979	be	_	_	_	_
7-16	980-990	considered	_	_	_	_
7-17	991-994	for	_	_	_	_
7-18	995-1004	long-term	event[53]	new[53]	_	_
7-19	1005-1017	implantation	event[53]	new[53]	_	_
7-20	1018-1019	,	_	_	_	_
7-21	1020-1028	combined	_	_	_	_
7-22	1029-1033	with	_	_	_	_
7-23	1034-1044	sensorless	abstract|abstract[55]	giv|new[55]	coref	13-19
7-24	1045-1052	signals	abstract[55]	new[55]	_	_
7-25	1053-1054	,	_	_	_	_
7-26	1055-1057	to	_	_	_	_
7-27	1058-1062	form	_	_	_	_
7-28	1063-1064	a	abstract[57]	new[57]	_	_
7-29	1065-1071	robust	abstract[57]	new[57]	_	_
7-30	1072-1079	control	person|abstract[57]	new|new[57]	_	_
7-31	1080-1086	system	abstract[57]	new[57]	_	_
7-32	1087-1091	that	_	_	_	_
7-33	1092-1100	provides	_	_	_	_
7-34	1101-1114	physiological	abstract[58]	new[58]	_	_
7-35	1115-1123	behavior	abstract[58]	new[58]	_	_
7-36	1124-1126	to	_	_	_	_
7-37	1127-1131	RBPs	abstract	new	_	_
7-38	1132-1133	.	_	_	_	_

#Text=The pulsatile flow pump is used as a non-invasive substitute for the LV filling pressure , as it has been proven to be closely interrelated .
8-1	1134-1137	The	object[61]	giv[61]	coref	9-1[65_61]
8-2	1138-1147	pulsatile	object[61]	giv[61]	_	_
8-3	1148-1152	flow	abstract|object[61]	giv|giv[61]	coref	9-7
8-4	1153-1157	pump	object[61]	giv[61]	_	_
8-5	1158-1160	is	_	_	_	_
8-6	1161-1165	used	_	_	_	_
8-7	1166-1168	as	_	_	_	_
8-8	1169-1170	a	_	_	_	_
8-9	1171-1183	non-invasive	_	_	_	_
8-10	1184-1194	substitute	_	_	_	_
8-11	1195-1198	for	_	_	_	_
8-12	1199-1202	the	substance[62]	new[62]	_	_
8-13	1203-1205	LV	substance[62]	new[62]	_	_
8-14	1206-1213	filling	_	_	_	_
8-15	1214-1222	pressure	abstract	giv	ana	8-18
8-16	1223-1224	,	_	_	_	_
8-17	1225-1227	as	_	_	_	_
8-18	1228-1230	it	abstract	giv	_	_
8-19	1231-1234	has	_	_	_	_
8-20	1235-1239	been	_	_	_	_
8-21	1240-1246	proven	_	_	_	_
8-22	1247-1249	to	_	_	_	_
8-23	1250-1252	be	_	_	_	_
8-24	1253-1260	closely	_	_	_	_
8-25	1261-1273	interrelated	_	_	_	_
8-26	1274-1275	.	_	_	_	_

#Text=The pump flow pulsation and mean flow pump used in the current controller can be estimated using an algorithm for flow estimation previously established in our laboratory using the pump speed and current that are not measured invasively .
9-1	1276-1279	The	object[65]	giv[65]	coref	9-7[68_65]
9-2	1280-1284	pump	object[65]	giv[65]	_	_
9-3	1285-1289	flow	_	_	_	_
9-4	1290-1299	pulsation	abstract	new	_	_
9-5	1300-1303	and	_	_	_	_
9-6	1304-1308	mean	_	_	_	_
9-7	1309-1313	flow	abstract|object[68]	giv|giv[68]	coref|coref	9-21|9-30[0_68]
9-8	1314-1318	pump	object[68]	giv[68]	_	_
9-9	1319-1323	used	_	_	_	_
9-10	1324-1326	in	_	_	_	_
9-11	1327-1330	the	object[69]	giv[69]	coref	14-8[122_69]
9-12	1331-1338	current	object[69]	giv[69]	_	_
9-13	1339-1349	controller	object[69]	giv[69]	_	_
9-14	1350-1353	can	_	_	_	_
9-15	1354-1356	be	_	_	_	_
9-16	1357-1366	estimated	_	_	_	_
9-17	1367-1372	using	_	_	_	_
9-18	1373-1375	an	abstract[70]	new[70]	_	_
9-19	1376-1385	algorithm	abstract[70]	new[70]	_	_
9-20	1386-1389	for	abstract[70]	new[70]	_	_
9-21	1390-1394	flow	abstract[70]|abstract|abstract[72]	new[70]|giv|new[72]	coref	10-6
9-22	1395-1405	estimation	abstract[70]|abstract[72]	new[70]|new[72]	_	_
9-23	1406-1416	previously	_	_	_	_
9-24	1417-1428	established	_	_	_	_
9-25	1429-1431	in	_	_	_	_
9-26	1432-1435	our	person|place[74]	giv|new[74]	_	_
9-27	1436-1446	laboratory	place[74]	new[74]	_	_
9-28	1447-1452	using	_	_	_	_
9-29	1453-1456	the	abstract[76]	new[76]	coref	14-23[127_76]
9-30	1457-1461	pump	object|abstract[76]	giv|new[76]	coref	11-19
9-31	1462-1467	speed	abstract[76]	new[76]	_	_
9-32	1468-1471	and	_	_	_	_
9-33	1472-1479	current	_	_	_	_
9-34	1480-1484	that	_	_	_	_
9-35	1485-1488	are	_	_	_	_
9-36	1489-1492	not	_	_	_	_
9-37	1493-1501	measured	_	_	_	_
9-38	1502-1512	invasively	_	_	_	_
9-39	1513-1514	.	_	_	_	_

#Text=The current control approach uses flow pulsatility as a parameter to determine the required flow rate compared to the continuous pulsatility index ( PI ) control strategy , which regulates PI directly at a specific stage .
10-1	1515-1518	The	abstract[78]	new[78]	_	_
10-2	1519-1526	current	abstract[78]	new[78]	_	_
10-3	1527-1534	control	event|abstract[78]	giv|new[78]	coref	10-26
10-4	1535-1543	approach	abstract[78]	new[78]	_	_
10-5	1544-1548	uses	_	_	_	_
10-6	1549-1553	flow	abstract|abstract[80]	giv|new[80]	coref|coref	10-15|10-21[0_80]
10-7	1554-1565	pulsatility	abstract[80]	new[80]	_	_
10-8	1566-1568	as	_	_	_	_
10-9	1569-1570	a	_	_	_	_
10-10	1571-1580	parameter	_	_	_	_
10-11	1581-1583	to	_	_	_	_
10-12	1584-1593	determine	_	_	_	_
10-13	1594-1597	the	abstract[82]	giv[82]	_	_
10-14	1598-1606	required	abstract[82]	giv[82]	_	_
10-15	1607-1611	flow	abstract|abstract[82]	giv|giv[82]	_	_
10-16	1612-1616	rate	abstract[82]	giv[82]	_	_
10-17	1617-1625	compared	_	_	_	_
10-18	1626-1628	to	_	_	_	_
10-19	1629-1632	the	abstract[84]	new[84]	appos	10-24[0_84]
10-20	1633-1643	continuous	abstract[84]	new[84]	_	_
10-21	1644-1655	pulsatility	abstract|abstract[84]	giv|new[84]	coref	11-15[95_0]
10-22	1656-1661	index	abstract[84]	new[84]	_	_
10-23	1662-1663	(	_	_	_	_
10-24	1664-1666	PI	abstract	giv	coref	10-31
10-25	1667-1668	)	_	_	_	_
10-26	1669-1676	control	event|abstract[87]	giv|new[87]	coref	13-16
10-27	1677-1685	strategy	abstract[87]	new[87]	_	_
10-28	1686-1687	,	_	_	_	_
10-29	1688-1693	which	_	_	_	_
10-30	1694-1703	regulates	_	_	_	_
10-31	1704-1706	PI	abstract	giv	coref	11-38
10-32	1707-1715	directly	_	_	_	_
10-33	1716-1718	at	_	_	_	_
10-34	1719-1720	a	abstract[89]	new[89]	ana	11-1[0_89]
10-35	1721-1729	specific	abstract[89]	new[89]	_	_
10-36	1730-1735	stage	abstract[89]	new[89]	_	_
10-37	1736-1737	.	_	_	_	_

#Text=This allows the left ventricle to automatically adjust the RV output ( represented by the increased or decreased pump pulsatility ) , thereby decreasing the danger of suction or an inefficient pumping aid connected to improperly defined PI target values .
11-1	1738-1742	This	abstract	giv	_	_
11-2	1743-1749	allows	_	_	_	_
11-3	1750-1753	the	object[91]	new[91]	_	_
11-4	1754-1758	left	object[91]	new[91]	_	_
11-5	1759-1768	ventricle	object[91]	new[91]	_	_
11-6	1769-1771	to	_	_	_	_
11-7	1772-1785	automatically	_	_	_	_
11-8	1786-1792	adjust	_	_	_	_
11-9	1793-1796	the	abstract[93]	new[93]	_	_
11-10	1797-1799	RV	abstract|abstract[93]	new|new[93]	_	_
11-11	1800-1806	output	abstract[93]	new[93]	_	_
11-12	1807-1808	(	_	_	_	_
11-13	1809-1820	represented	_	_	_	_
11-14	1821-1823	by	_	_	_	_
11-15	1824-1827	the	abstract[95]	giv[95]	_	_
11-16	1828-1837	increased	abstract[95]	giv[95]	_	_
11-17	1838-1840	or	abstract[95]	giv[95]	_	_
11-18	1841-1850	decreased	abstract[95]	giv[95]	_	_
11-19	1851-1855	pump	object|abstract[95]	giv|giv[95]	_	_
11-20	1856-1867	pulsatility	abstract[95]	giv[95]	_	_
11-21	1868-1869	)	_	_	_	_
11-22	1870-1871	,	_	_	_	_
11-23	1872-1879	thereby	_	_	_	_
11-24	1880-1890	decreasing	_	_	_	_
11-25	1891-1894	the	abstract[96]	new[96]	_	_
11-26	1895-1901	danger	abstract[96]	new[96]	_	_
11-27	1902-1904	of	abstract[96]	new[96]	_	_
11-28	1905-1912	suction	abstract[96]|event	new[96]|new	_	_
11-29	1913-1915	or	abstract[96]	new[96]	_	_
11-30	1916-1918	an	abstract[96]|abstract[99]	new[96]|new[99]	_	_
11-31	1919-1930	inefficient	abstract[96]|abstract[99]	new[96]|new[99]	_	_
11-32	1931-1938	pumping	abstract[96]|abstract|abstract[99]	new[96]|new|new[99]	_	_
11-33	1939-1942	aid	abstract[96]|abstract[99]	new[96]|new[99]	_	_
11-34	1943-1952	connected	_	_	_	_
11-35	1953-1955	to	_	_	_	_
11-36	1956-1966	improperly	_	_	_	_
11-37	1967-1974	defined	_	_	_	_
11-38	1975-1977	PI	abstract|abstract[102]	giv|new[102]	coref	12-4
11-39	1978-1984	target	abstract|abstract[102]	new|new[102]	coref	12-3
11-40	1985-1991	values	abstract[102]	new[102]	_	_
11-41	1992-1993	.	_	_	_	_

#Text=The optimal target PI value depends on heart contractility , preload , and afterload .
12-1	1994-1997	The	quantity[105]	new[105]	_	_
12-2	1998-2005	optimal	quantity[105]	new[105]	_	_
12-3	2006-2012	target	abstract|quantity[105]	giv|new[105]	_	_
12-4	2013-2015	PI	abstract|quantity[105]	giv|new[105]	coref	40-9
12-5	2016-2021	value	quantity[105]	new[105]	_	_
12-6	2022-2029	depends	_	_	_	_
12-7	2030-2032	on	_	_	_	_
12-8	2033-2038	heart	abstract|abstract[107]	new|new[107]	coref	31-15[143_107]
12-9	2039-2052	contractility	abstract[107]	new[107]	_	_
12-10	2053-2054	,	_	_	_	_
12-11	2055-2062	preload	abstract	giv	_	_
12-12	2063-2064	,	_	_	_	_
12-13	2065-2068	and	_	_	_	_
12-14	2069-2078	afterload	abstract	new	_	_
12-15	2079-2080	.	_	_	_	_

#Text=The methodology of this work is proposed to evaluate the merits of a full-state feedback control method involving sensorless and non-invasive approaches in a range of identical simulation scenarios .
13-1	2081-2084	The	abstract[110]	new[110]	_	_
13-2	2085-2096	methodology	abstract[110]	new[110]	_	_
13-3	2097-2099	of	abstract[110]	new[110]	_	_
13-4	2100-2104	this	abstract[110]|abstract[111]	new[110]|new[111]	_	_
13-5	2105-2109	work	abstract[110]|abstract[111]	new[110]|new[111]	_	_
13-6	2110-2112	is	_	_	_	_
13-7	2113-2121	proposed	_	_	_	_
13-8	2122-2124	to	_	_	_	_
13-9	2125-2133	evaluate	_	_	_	_
13-10	2134-2137	the	abstract[112]	new[112]	_	_
13-11	2138-2144	merits	abstract[112]	new[112]	_	_
13-12	2145-2147	of	abstract[112]	new[112]	_	_
13-13	2148-2149	a	abstract[112]|abstract[115]	new[112]|new[115]	coref	14-4[121_115]
13-14	2150-2160	full-state	abstract[112]|abstract[115]	new[112]|new[115]	_	_
13-15	2161-2169	feedback	abstract[112]|abstract|abstract[115]	new[112]|new|new[115]	_	_
13-16	2170-2177	control	abstract[112]|event|abstract[115]	new[112]|giv|new[115]	_	_
13-17	2178-2184	method	abstract[112]|abstract[115]	new[112]|new[115]	_	_
13-18	2185-2194	involving	_	_	_	_
13-19	2195-2205	sensorless	abstract	giv	_	_
13-20	2206-2209	and	_	_	_	_
13-21	2210-2222	non-invasive	_	_	_	_
13-22	2223-2233	approaches	abstract	giv	_	_
13-23	2234-2236	in	_	_	_	_
13-24	2237-2238	a	_	_	_	_
13-25	2239-2244	range	_	_	_	_
13-26	2245-2247	of	_	_	_	_
13-27	2248-2257	identical	event[119]	new[119]	coref	33-15[158_119]
13-28	2258-2268	simulation	abstract|event[119]	new|new[119]	coref	31-3
13-29	2269-2278	scenarios	event[119]	new[119]	_	_
13-30	2279-2280	.	_	_	_	_

#Text=The results of this method show that the controller has advantages in regulating the reference signal generated with the safe mode at a variable speed , as illustrated in
14-1	2281-2284	The	abstract[120]	new[120]	_	_
14-2	2285-2292	results	abstract[120]	new[120]	_	_
14-3	2293-2295	of	abstract[120]	new[120]	_	_
14-4	2296-2300	this	abstract[120]|abstract[121]	new[120]|giv[121]	_	_
14-5	2301-2307	method	abstract[120]|abstract[121]	new[120]|giv[121]	_	_
14-6	2308-2312	show	_	_	_	_
14-7	2313-2317	that	_	_	_	_
14-8	2318-2321	the	object[122]	giv[122]	_	_
14-9	2322-2332	controller	object[122]	giv[122]	_	_
14-10	2333-2336	has	_	_	_	_
14-11	2337-2347	advantages	abstract	new	_	_
14-12	2348-2350	in	_	_	_	_
14-13	2351-2361	regulating	_	_	_	_
14-14	2362-2365	the	abstract[125]	new[125]	_	_
14-15	2366-2375	reference	abstract|abstract[125]	new|new[125]	_	_
14-16	2376-2382	signal	abstract[125]	new[125]	_	_
14-17	2383-2392	generated	_	_	_	_
14-18	2393-2397	with	_	_	_	_
14-19	2398-2401	the	abstract[126]	new[126]	_	_
14-20	2402-2406	safe	abstract[126]	new[126]	_	_
14-21	2407-2411	mode	abstract[126]	new[126]	_	_
14-22	2412-2414	at	abstract[126]	new[126]	_	_
14-23	2415-2416	a	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-24	2417-2425	variable	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-25	2426-2431	speed	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-26	2432-2433	,	_	_	_	_
14-27	2434-2436	as	_	_	_	_
14-28	2437-2448	illustrated	_	_	_	_
14-29	2449-2451	in	_	_	_	_

#Text=Figure 4
15-1	2452-2458	Figure	abstract[128]	new[128]	_	_
15-2	2459-2460	4	abstract[128]	new[128]	_	_

#Text=,
16-1	2461-2462	,	_	_	_	_

#Text=Figure 5
17-1	2463-2469	Figure	abstract[129]	new[129]	_	_
17-2	2470-2471	5	abstract[129]	new[129]	_	_

#Text=,
18-1	2472-2473	,	_	_	_	_

#Text=Figure 6
19-1	2474-2480	Figure	object[130]	new[130]	_	_
19-2	2481-2482	6	object[130]	new[130]	_	_

#Text=,
20-1	2483-2484	,	_	_	_	_

#Text=Figure 7
21-1	2485-2491	Figure	abstract[131]	new[131]	_	_
21-2	2492-2493	7	abstract[131]	new[131]	_	_

#Text=,
22-1	2494-2495	,	_	_	_	_

#Text=Figure 8
23-1	2496-2502	Figure	abstract[132]	new[132]	_	_
23-2	2503-2504	8	abstract[132]	new[132]	_	_

#Text=,
24-1	2505-2506	,	_	_	_	_

#Text=Figure 9
25-1	2507-2513	Figure	abstract[133]	new[133]	_	_
25-2	2514-2515	9	abstract[133]	new[133]	_	_

#Text=,
26-1	2516-2517	,	_	_	_	_

#Text=Figure 10
27-1	2518-2524	Figure	abstract[134]	new[134]	_	_
27-2	2525-2527	10	abstract[134]	new[134]	_	_

#Text=and
28-1	2528-2531	and	_	_	_	_

#Text=Figure 11
29-1	2532-2538	Figure	abstract[135]	new[135]	_	_
29-2	2539-2541	11	abstract[135]	new[135]	_	_

#Text=.
30-1	2542-2543	.	_	_	_	_

#Text=The software simulation model currently simulates rest and exercise with changes in HR , cardiac contractility , and systemic vascular resistance .
31-1	2544-2547	The	abstract[138]	new[138]	coref	33-10[157_138]
31-2	2548-2556	software	object|abstract[138]	new|new[138]	coref	33-11
31-3	2557-2567	simulation	abstract|abstract[138]	giv|new[138]	coref	41-17
31-4	2568-2573	model	abstract[138]	new[138]	_	_
31-5	2574-2583	currently	_	_	_	_
31-6	2584-2593	simulates	_	_	_	_
31-7	2594-2598	rest	event	new	_	_
31-8	2599-2602	and	_	_	_	_
31-9	2603-2611	exercise	event[140]	new[140]	coref	35-14[0_140]
31-10	2612-2616	with	event[140]	new[140]	_	_
31-11	2617-2624	changes	event[140]|abstract[141]	new[140]|new[141]	coref	32-7[146_141]
31-12	2625-2627	in	event[140]|abstract[141]	new[140]|new[141]	_	_
31-13	2628-2630	HR	event[140]|abstract[141]|time	new[140]|new[141]|new	_	_
31-14	2631-2632	,	event[140]|abstract[141]	new[140]|new[141]	_	_
31-15	2633-2640	cardiac	event[140]|abstract[141]|abstract[143]	new[140]|new[141]|giv[143]	_	_
31-16	2641-2654	contractility	event[140]|abstract[141]|abstract[143]	new[140]|new[141]|giv[143]	_	_
31-17	2655-2656	,	event[140]|abstract[141]	new[140]|new[141]	_	_
31-18	2657-2660	and	event[140]|abstract[141]	new[140]|new[141]	_	_
31-19	2661-2669	systemic	event[140]|abstract[141]|abstract[144]	new[140]|new[141]|new[144]	ana	32-3[0_144]
31-20	2670-2678	vascular	event[140]|abstract[141]|abstract[144]	new[140]|new[141]|new[144]	_	_
31-21	2679-2689	resistance	event[140]|abstract[141]|abstract[144]	new[140]|new[141]|new[144]	_	_
31-22	2690-2691	.	_	_	_	_

#Text=Clinically , it is observed that large changes in pump pulsatility during postural changes cause patients to sometimes feel weak during Valsalva maneuvers ( e. g. , when coughing or straining ) .
32-1	2692-2702	Clinically	_	_	_	_
32-2	2703-2704	,	_	_	_	_
32-3	2705-2707	it	abstract	giv	coref	36-11
32-4	2708-2710	is	_	_	_	_
32-5	2711-2719	observed	_	_	_	_
32-6	2720-2724	that	_	_	_	_
32-7	2725-2730	large	abstract[146]	giv[146]	_	_
32-8	2731-2738	changes	abstract[146]	giv[146]	_	_
32-9	2739-2741	in	abstract[146]	giv[146]	_	_
32-10	2742-2746	pump	abstract[146]|object|abstract[148]	giv[146]|new|new[148]	coref	38-17[0_148]
32-11	2747-2758	pulsatility	abstract[146]|abstract[148]	giv[146]|new[148]	_	_
32-12	2759-2765	during	abstract[146]|abstract[148]	giv[146]|new[148]	_	_
32-13	2766-2774	postural	abstract[146]|abstract[148]	giv[146]|new[148]	_	_
32-14	2775-2782	changes	abstract[146]|abstract[148]	giv[146]|new[148]	_	_
32-15	2783-2788	cause	_	_	_	_
32-16	2789-2797	patients	person	new	coref	34-13[162_0]
32-17	2798-2800	to	_	_	_	_
32-18	2801-2810	sometimes	_	_	_	_
32-19	2811-2815	feel	_	_	_	_
32-20	2816-2820	weak	_	_	_	_
32-21	2821-2827	during	_	_	_	_
32-22	2828-2836	Valsalva	person|abstract[151]	new|new[151]	appos	32-25[152_151]
32-23	2837-2846	maneuvers	abstract[151]	new[151]	_	_
32-24	2847-2848	(	_	_	_	_
32-25	2849-2851	e.	abstract[152]	giv[152]	_	_
32-26	2852-2854	g.	abstract[152]	giv[152]	_	_
32-27	2855-2856	,	_	_	_	_
32-28	2857-2861	when	_	_	_	_
32-29	2862-2870	coughing	_	_	_	_
32-30	2871-2873	or	_	_	_	_
32-31	2874-2883	straining	_	_	_	_
32-32	2884-2885	)	_	_	_	_
32-33	2886-2887	.	_	_	_	_

#Text=Therefore , we believe it is important to improve the software model to represent these events .
33-1	2888-2897	Therefore	_	_	_	_
33-2	2898-2899	,	_	_	_	_
33-3	2900-2902	we	person	acc	ana	36-1
33-4	2903-2910	believe	_	_	_	_
33-5	2911-2913	it	abstract	new	cata	33-5[0_155]
33-6	2914-2916	is	_	_	_	_
33-7	2917-2926	important	_	_	_	_
33-8	2927-2929	to	abstract[155]	new[155]	_	_
33-9	2930-2937	improve	abstract[155]	new[155]	_	_
33-10	2938-2941	the	abstract[155]|abstract[157]	new[155]|giv[157]	_	_
33-11	2942-2950	software	abstract[155]|object|abstract[157]	new[155]|giv|giv[157]	_	_
33-12	2951-2956	model	abstract[155]|abstract[157]	new[155]|giv[157]	_	_
33-13	2957-2959	to	_	_	_	_
33-14	2960-2969	represent	_	_	_	_
33-15	2970-2975	these	event[158]	giv[158]	_	_
33-16	2976-2982	events	event[158]	giv[158]	_	_
33-17	2983-2984	.	_	_	_	_

#Text=In addition , the aortic valve is observed to be closed in most LVAD patients .
34-1	2985-2987	In	_	_	_	_
34-2	2988-2996	addition	_	_	_	_
34-3	2997-2998	,	_	_	_	_
34-4	2999-3002	the	object[160]	new[160]	coref	36-5[171_160]
34-5	3003-3009	aortic	abstract|object[160]	new|new[160]	coref	36-6
34-6	3010-3015	valve	object[160]	new[160]	_	_
34-7	3016-3018	is	_	_	_	_
34-8	3019-3027	observed	_	_	_	_
34-9	3028-3030	to	_	_	_	_
34-10	3031-3033	be	_	_	_	_
34-11	3034-3040	closed	_	_	_	_
34-12	3041-3043	in	_	_	_	_
34-13	3044-3048	most	person[162]	giv[162]	_	_
34-14	3049-3053	LVAD	abstract|person[162]	new|giv[162]	coref	36-15
34-15	3054-3062	patients	person[162]	giv[162]	_	_
34-16	3063-3064	.	_	_	_	_

#Text=However , with a change in posture , cardiac recovery , and during exercise , it may open .
35-1	3065-3072	However	_	_	_	_
35-2	3073-3074	,	_	_	_	_
35-3	3075-3079	with	_	_	_	_
35-4	3080-3081	a	event[163]	new[163]	_	_
35-5	3082-3088	change	event[163]	new[163]	_	_
35-6	3089-3091	in	event[163]	new[163]	_	_
35-7	3092-3099	posture	event[163]|abstract	new[163]|new	_	_
35-8	3100-3101	,	event[163]	new[163]	_	_
35-9	3102-3109	cardiac	event[163]|person|event[166]	new[163]|new|new[166]	_	_
35-10	3110-3118	recovery	event[163]|event[166]	new[163]|new[166]	_	_
35-11	3119-3120	,	_	_	_	_
35-12	3121-3124	and	_	_	_	_
35-13	3125-3131	during	_	_	_	_
35-14	3132-3140	exercise	event	giv	ana	35-16
35-15	3141-3142	,	_	_	_	_
35-16	3143-3145	it	event	giv	_	_
35-17	3146-3149	may	_	_	_	_
35-18	3150-3154	open	_	_	_	_
35-19	3155-3156	.	_	_	_	_

#Text=We have found that the aortic valve offers a lower resistance pathway than the LVAD bypass route , as the native heart sometimes pumps a significant flow relative to that of the LVAD .
36-1	3157-3159	We	person	giv	ana	37-3
36-2	3160-3164	have	_	_	_	_
36-3	3165-3170	found	_	_	_	_
36-4	3171-3175	that	_	_	_	_
36-5	3176-3179	the	object[171]	giv[171]	_	_
36-6	3180-3186	aortic	abstract|object[171]	giv|giv[171]	_	_
36-7	3187-3192	valve	object[171]	giv[171]	_	_
36-8	3193-3199	offers	_	_	_	_
36-9	3200-3201	a	place[173]	new[173]	ana	36-30[179_173]
36-10	3202-3207	lower	place[173]	new[173]	_	_
36-11	3208-3218	resistance	abstract|place[173]	giv|new[173]	_	_
36-12	3219-3226	pathway	place[173]	new[173]	_	_
36-13	3227-3231	than	place[173]	new[173]	_	_
36-14	3232-3235	the	place[173]|abstract[176]	new[173]|new[176]	_	_
36-15	3236-3240	LVAD	place[173]|abstract|abstract[176]	new[173]|giv|new[176]	coref	36-32[180_0]
36-16	3241-3247	bypass	place[173]|object|abstract[176]	new[173]|new|new[176]	_	_
36-17	3248-3253	route	place[173]|abstract[176]	new[173]|new[176]	_	_
36-18	3254-3255	,	_	_	_	_
36-19	3256-3258	as	_	_	_	_
36-20	3259-3262	the	abstract[177]	new[177]	coref	40-15[0_177]
36-21	3263-3269	native	abstract[177]	new[177]	_	_
36-22	3270-3275	heart	abstract[177]	new[177]	_	_
36-23	3276-3285	sometimes	_	_	_	_
36-24	3286-3291	pumps	_	_	_	_
36-25	3292-3293	a	abstract[178]	new[178]	_	_
36-26	3294-3305	significant	abstract[178]	new[178]	_	_
36-27	3306-3310	flow	abstract[178]	new[178]	_	_
36-28	3311-3319	relative	abstract[178]	new[178]	_	_
36-29	3320-3322	to	_	_	_	_
36-30	3323-3327	that	place[179]	giv[179]	_	_
36-31	3328-3330	of	place[179]	giv[179]	_	_
36-32	3331-3334	the	place[179]|abstract[180]	giv[179]|giv[180]	coref	42-18[0_180]
36-33	3335-3339	LVAD	place[179]|abstract[180]	giv[179]|giv[180]	_	_
36-34	3340-3341	.	_	_	_	_

#Text=Therefore , we believe that this different pumping state could greatly impact our overall control strategy , and therefore requires online detection .
37-1	3342-3351	Therefore	_	_	_	_
37-2	3352-3353	,	_	_	_	_
37-3	3354-3356	we	person	giv	ana	37-13
37-4	3357-3364	believe	_	_	_	_
37-5	3365-3369	that	_	_	_	_
37-6	3370-3374	this	abstract[183]	new[183]	_	_
37-7	3375-3384	different	abstract[183]	new[183]	_	_
37-8	3385-3392	pumping	abstract|abstract[183]	new|new[183]	_	_
37-9	3393-3398	state	abstract[183]	new[183]	_	_
37-10	3399-3404	could	_	_	_	_
37-11	3405-3412	greatly	_	_	_	_
37-12	3413-3419	impact	_	_	_	_
37-13	3420-3423	our	person|abstract[186]	giv|new[186]	ana	41-6
37-14	3424-3431	overall	abstract[186]	new[186]	_	_
37-15	3432-3439	control	abstract|abstract[186]	new|new[186]	_	_
37-16	3440-3448	strategy	abstract[186]	new[186]	_	_
37-17	3449-3450	,	_	_	_	_
37-18	3451-3454	and	_	_	_	_
37-19	3455-3464	therefore	_	_	_	_
37-20	3465-3473	requires	_	_	_	_
37-21	3474-3480	online	abstract[187]	new[187]	_	_
37-22	3481-3490	detection	abstract[187]	new[187]	_	_
37-23	3491-3492	.	_	_	_	_

#Text=In addition , during use in a clinical setting , it was found that controlling the pulsatility index to a pre-set point did not prevent antagonistic pumping states .
38-1	3493-3495	In	_	_	_	_
38-2	3496-3504	addition	_	_	_	_
38-3	3505-3506	,	_	_	_	_
38-4	3507-3513	during	_	_	_	_
38-5	3514-3517	use	abstract[188]	new[188]	_	_
38-6	3518-3520	in	abstract[188]	new[188]	_	_
38-7	3521-3522	a	abstract[188]|abstract[189]	new[188]|new[189]	ana	38-11[0_189]
38-8	3523-3531	clinical	abstract[188]|abstract[189]	new[188]|new[189]	_	_
38-9	3532-3539	setting	abstract[188]|abstract[189]	new[188]|new[189]	_	_
38-10	3540-3541	,	_	_	_	_
38-11	3542-3544	it	abstract	giv	_	_
38-12	3545-3548	was	_	_	_	_
38-13	3549-3554	found	_	_	_	_
38-14	3555-3559	that	_	_	_	_
38-15	3560-3571	controlling	_	_	_	_
38-16	3572-3575	the	abstract[192]	new[192]	coref	40-5[201_192]
38-17	3576-3587	pulsatility	abstract|abstract[192]	giv|new[192]	coref	40-6
38-18	3588-3593	index	abstract[192]	new[192]	_	_
38-19	3594-3596	to	_	_	_	_
38-20	3597-3598	a	abstract[193]	new[193]	_	_
38-21	3599-3606	pre-set	abstract[193]	new[193]	_	_
38-22	3607-3612	point	abstract[193]	new[193]	_	_
38-23	3613-3616	did	_	_	_	_
38-24	3617-3620	not	_	_	_	_
38-25	3621-3628	prevent	_	_	_	_
38-26	3629-3641	antagonistic	abstract[194]	new[194]	_	_
38-27	3642-3649	pumping	abstract[194]	new[194]	_	_
38-28	3650-3656	states	abstract[194]	new[194]	_	_
38-29	3657-3658	.	_	_	_	_

#Text=On the contrary , occasional suction occurred , which led to the development of algorithms for anti-suction .
39-1	3659-3661	On	_	_	_	_
39-2	3662-3665	the	_	_	_	_
39-3	3666-3674	contrary	_	_	_	_
39-4	3675-3676	,	_	_	_	_
39-5	3677-3687	occasional	abstract[195]	new[195]	_	_
39-6	3688-3695	suction	abstract[195]	new[195]	_	_
39-7	3696-3704	occurred	_	_	_	_
39-8	3705-3706	,	_	_	_	_
39-9	3707-3712	which	_	_	_	_
39-10	3713-3716	led	_	_	_	_
39-11	3717-3719	to	_	_	_	_
39-12	3720-3723	the	abstract[196]	new[196]	_	_
39-13	3724-3735	development	abstract[196]	new[196]	_	_
39-14	3736-3738	of	abstract[196]	new[196]	_	_
39-15	3739-3749	algorithms	abstract[196]|abstract[197]	new[196]|new[197]	_	_
39-16	3750-3753	for	abstract[196]|abstract[197]	new[196]|new[197]	_	_
39-17	3754-3766	anti-suction	abstract[196]|abstract[197]|abstract	new[196]|new[197]|new	_	_
39-18	3767-3768	.	_	_	_	_

#Text=Another drawback is that the pulsatility index ( PI ) is increasingly dependent on heart rate .
40-1	3769-3776	Another	abstract[199]	new[199]	_	_
40-2	3777-3785	drawback	abstract[199]	new[199]	_	_
40-3	3786-3788	is	_	_	_	_
40-4	3789-3793	that	_	_	_	_
40-5	3794-3797	the	abstract[201]	giv[201]	_	_
40-6	3798-3809	pulsatility	abstract|abstract[201]	giv|giv[201]	_	_
40-7	3810-3815	index	abstract[201]	giv[201]	_	_
40-8	3816-3817	(	_	_	_	_
40-9	3818-3820	PI	abstract	giv	_	_
40-10	3821-3822	)	_	_	_	_
40-11	3823-3825	is	_	_	_	_
40-12	3826-3838	increasingly	_	_	_	_
40-13	3839-3848	dependent	_	_	_	_
40-14	3849-3851	on	_	_	_	_
40-15	3852-3857	heart	abstract|abstract[204]	giv|new[204]	ana	42-1[0_204]
40-16	3858-3862	rate	abstract[204]	new[204]	_	_
40-17	3863-3864	.	_	_	_	_

#Text=For real-time clinical studies , we plan to validate the controller built in the above-mentioned computer simulation studies in a pulsatile mock circulation loop .
41-1	3865-3868	For	_	_	_	_
41-2	3869-3878	real-time	event[205]	new[205]	coref	41-14[210_205]
41-3	3879-3887	clinical	event[205]	new[205]	_	_
41-4	3888-3895	studies	event[205]	new[205]	_	_
41-5	3896-3897	,	_	_	_	_
41-6	3898-3900	we	person	giv	_	_
41-7	3901-3905	plan	_	_	_	_
41-8	3906-3908	to	_	_	_	_
41-9	3909-3917	validate	_	_	_	_
41-10	3918-3921	the	object[207]	new[207]	coref	42-17[222_207]
41-11	3922-3932	controller	object[207]	new[207]	_	_
41-12	3933-3938	built	_	_	_	_
41-13	3939-3941	in	_	_	_	_
41-14	3942-3945	the	event[210]	giv[210]	coref	43-9[226_210]
41-15	3946-3961	above-mentioned	event[210]	giv[210]	_	_
41-16	3962-3970	computer	object|event[210]	new|giv[210]	coref	43-2
41-17	3971-3981	simulation	abstract|event[210]	giv|giv[210]	_	_
41-18	3982-3989	studies	event[210]	giv[210]	_	_
41-19	3990-3992	in	event[210]	giv[210]	_	_
41-20	3993-3994	a	event[210]|object[213]	giv[210]|new[213]	_	_
41-21	3995-4004	pulsatile	event[210]|object[213]	giv[210]|new[213]	_	_
41-22	4005-4009	mock	event[210]|place|object[213]	giv[210]|new|new[213]	_	_
41-23	4010-4021	circulation	event[210]|abstract|object[213]	giv[210]|new|new[213]	_	_
41-24	4022-4026	loop	event[210]|object[213]	giv[210]|new[213]	_	_
41-25	4027-4028	.	_	_	_	_

#Text=This will include the design of a LabView/MATLAB system for the implementation of control strategies in the LVAD physical controller .
42-1	4029-4033	This	abstract	giv	_	_
42-2	4034-4038	will	_	_	_	_
42-3	4039-4046	include	_	_	_	_
42-4	4047-4050	the	abstract[215]	new[215]	_	_
42-5	4051-4057	design	abstract[215]	new[215]	_	_
42-6	4058-4060	of	abstract[215]	new[215]	_	_
42-7	4061-4062	a	abstract[215]|object[217]	new[215]|new[217]	coref	43-1[224_217]
42-8	4063-4077	LabView/MATLAB	abstract[215]|organization|object[217]	new[215]|new|new[217]	_	_
42-9	4078-4084	system	abstract[215]|object[217]	new[215]|new[217]	_	_
42-10	4085-4088	for	abstract[215]	new[215]	_	_
42-11	4089-4092	the	abstract[215]|abstract[218]	new[215]|new[218]	_	_
42-12	4093-4107	implementation	abstract[215]|abstract[218]	new[215]|new[218]	_	_
42-13	4108-4110	of	abstract[215]|abstract[218]	new[215]|new[218]	_	_
42-14	4111-4118	control	abstract[215]|abstract[218]|person|abstract[220]	new[215]|new[218]|new|new[220]	_	_
42-15	4119-4129	strategies	abstract[215]|abstract[218]|abstract[220]	new[215]|new[218]|new[220]	_	_
42-16	4130-4132	in	abstract[215]|abstract[218]|abstract[220]	new[215]|new[218]|new[220]	_	_
42-17	4133-4136	the	abstract[215]|abstract[218]|abstract[220]|object[222]	new[215]|new[218]|new[220]|giv[222]	_	_
42-18	4137-4141	LVAD	abstract[215]|abstract[218]|abstract[220]|abstract|object[222]	new[215]|new[218]|new[220]|giv|giv[222]	_	_
42-19	4142-4150	physical	abstract[215]|abstract[218]|abstract[220]|object[222]	new[215]|new[218]|new[220]|giv[222]	_	_
42-20	4151-4161	controller	abstract[215]|abstract[218]|abstract[220]|object[222]	new[215]|new[218]|new[220]|giv[222]	_	_
42-21	4162-4163	.	_	_	_	_

#Text=This computer system will then be used in acute animal studies .
43-1	4164-4168	This	object[224]	giv[224]	_	_
43-2	4169-4177	computer	object|object[224]	giv|giv[224]	_	_
43-3	4178-4184	system	object[224]	giv[224]	_	_
43-4	4185-4189	will	_	_	_	_
43-5	4190-4194	then	_	_	_	_
43-6	4195-4197	be	_	_	_	_
43-7	4198-4202	used	_	_	_	_
43-8	4203-4205	in	_	_	_	_
43-9	4206-4211	acute	event[226]	giv[226]	_	_
43-10	4212-4218	animal	animal|event[226]	new|giv[226]	_	_
43-11	4219-4226	studies	event[226]	giv[226]	_	_
43-12	4227-4228	.	_	_	_	_
